Document is current
Any future updates will be listed below
-
Authors
Ohmine, Ken https://orcid.org/0000-0001-6847-3056
Uchibori, Ryosuke
- License Information
-
More Information
Article History
Received: 13 April 2022
Revised: 18 April 2022
Accepted: 19 April 2022
First Online: 18 May 2022
Declarations
:
: K. Ohmine declares a consulting fee from Janssen, and speaker fees from BMS, Novartis, Janssen, and Ono, and grants from Takara Bio. and acted as a Data and Safety Monitoring Board in a trial sponsored by Ono. R. Uchibori declares grants from Takara Bio.
